PRIMARY STUDY

Evidence for the use of cannabinoids in Parkinson's disease

Key Findings:  The reviewers note that while there is an increasing understanding of how engaging the ECS might produce therapeutic effects in patients with PD, based on the available literature at the time of their review only one of four conducted randomized placebo-controlled trials produced therapeutic effect on motor symptoms with a of levodopa-induced dyskinesia.